We are delighted to share the news that ImCheck’s scientific founder and Clinical Advisory Board member, Prof. Daniel Olive, M.D., Ph.D. (INSERM, CNRS, Institut Paoli Calmettes, Aix-Marseille University) has been newly elected as the President of the French Society of Immunology (SFI). Daniel is a world-renowned researcher in immuno-oncology and has explored and elucidated the signaling pathways (notably ICOS and BTLA) bridging and controlling the activity of innate and adaptive immune cells. His work has led to the identification of immune cell populations that can be modulated through BTN(L)s, including gamma delta T cells and tumor associated macrophages (TAMs). In addition to ImCheck, Daniel’s research has enabled the foundation of several successful biotech companies in the space of immune-oncology. His leadership and contributions to immunology underscore this recognition by the SFI. Congratulations Daniel!